Literature DB >> 28877868

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Cynthia S Crowson1,2, Silvia Rollefstad3, Eirik Ikdahl3, George D Kitas4, Piet L C M van Riel5, Sherine E Gabriel2,6, Eric L Matteson2, Tore K Kvien3, Karen Douglas4, Aamer Sandoo4,7, Elke Arts5, Solveig Wållberg-Jonsson8, Lena Innala8, George Karpouzas9, Patrick H Dessein10,11, Linda Tsang11, Hani El-Gabalawy12, Carol Hitchon12, Virginia Pascual Ramos13, Irazú Contreras Yáñez13, Petros P Sfikakis14, Evangelia Zampeli14, Miguel A Gonzalez-Gay15, Alfonso Corrales15, Mart van de Laar16, Harald E Vonkeman16, Inger Meek16, Anne Grete Semb3.   

Abstract

OBJECTIVES: Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular disease (CVD). We aimed to assess the impact of CVD risk factors, including potential sex differences, and RA-specific variables on CVD outcome in a large, international cohort of patients with RA.
METHODS: In 13 rheumatology centres, data on CVD risk factors and RA characteristics were collected at baseline. CVD outcomes (myocardial infarction, angina, revascularisation, stroke, peripheral vascular disease and CVD death) were collected using standardised definitions.
RESULTS: 5638 patients with RA and no prior CVD were included (mean age: 55.3 (SD: 14.0) years, 76% women). During mean follow-up of 5.8 (SD: 4.4) years, 148 men and 241 women developed a CVD event (10-year cumulative incidence 20.9% and 11.1%, respectively). Men had a higher burden of CVD risk factors, including increased blood pressure, higher total cholesterol and smoking prevalence than women (all p<0.001). Among the traditional CVD risk factors, smoking and hypertension had the highest population attributable risk (PAR) overall and among both sexes, followed by total cholesterol. The PAR for Disease Activity Score and for seropositivity were comparable in magnitude to the PAR for lipids. A total of 70% of CVD events were attributable to all CVD risk factors and RA characteristics combined (separately 49% CVD risk factors and 30% RA characteristics).
CONCLUSIONS: In a large, international cohort of patients with RA, 30% of CVD events were attributable to RA characteristics. This finding indicates that RA characteristics play an important role in efforts to reduce CVD risk among patients with RA. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Cardiovascular disease; population attributable risk; rheumatoid arthritis; risk factor

Mesh:

Substances:

Year:  2017        PMID: 28877868      PMCID: PMC5726925          DOI: 10.1136/annrheumdis-2017-211735

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Authors:  E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

2.  Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study.

Authors:  A G Semb; T K Kvien; A H Aastveit; I Jungner; T R Pedersen; G Walldius; I Holme
Journal:  Ann Rheum Dis       Date:  2010-06-15       Impact factor: 19.103

3.  Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Eric L Matteson; Veronique L Roger; Terry M Therneau; Sherine E Gabriel
Journal:  Am J Cardiol       Date:  2012-04-20       Impact factor: 2.778

4.  Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study.

Authors:  P Schnohr; J S Jensen; H Scharling; B G Nordestgaard
Journal:  Eur Heart J       Date:  2002-04       Impact factor: 29.983

5.  Carotid plaque characteristics and disease activity in rheumatoid arthritis.

Authors:  Anne G Semb; Silvia Rollefstad; Sella A Provan; Tore K Kvien; Einar Stranden; Inge C Olsen; Jonny Hisdal
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

6.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity.

Authors:  K L Svenson; H Lithell; R Hällgren; I Selinus; B Vessby
Journal:  Arch Intern Med       Date:  1987-11

7.  Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.

Authors:  A G Semb; E Ikdahl; J Hisdal; I C Olsen; S Rollefstad
Journal:  Int J Cardiol       Date:  2016-08-07       Impact factor: 4.164

8.  Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study.

Authors:  Alfonso Corrales; Carlos González-Juanatey; María E Peiró; Ricardo Blanco; Javier Llorca; Miguel A González-Gay
Journal:  Ann Rheum Dis       Date:  2013-03-16       Impact factor: 19.103

9.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; S Wållberg-Jonsson; G Dahlén
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 10.  The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Leena R Baghdadi; Richard J Woodman; E Michael Shanahan; Arduino A Mangoni
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

View more
  55 in total

1.  Connecting Rheumatology Patients to Primary Care for High Blood Pressure: Specialty Clinic Protocol Improves Follow-up and Population Blood Pressures.

Authors:  Christie M Bartels; Edmond Ramly; Heather M Johnson; Diane R Lauver; Daniel J Panyard; Zhanhai Li; Emmanuel Sampene; Kristin Lewicki; Patrick E McBride
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

2.  Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Associations of Low Circulating Low-Density Lipoprotein Concentration With Subclinical Coronary Atherosclerosis.

Authors:  Jon T Giles; Mary Chester M Wasko; Cecilia P Chung; Moyses Szklo; Roger S Blumenthal; Amy Kao; Sabahat Bokhari; Afshin Zartoshti; C Michael Stein; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 10.995

Review 3.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

4.  Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.

Authors:  Jet J C S Veldhuijzen van Zanten; Aamer Sandoo; George S Metsios; Antonios Stavropoulos-Kalinoglou; Nikos Ntoumanis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

Review 5.  Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention.

Authors:  Neal S Parikh; Alexander E Merkler; Costantino Iadecola
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

Review 6.  Cardiovascular effects of approved drugs for rheumatoid arthritis.

Authors:  Fabiola Atzeni; Javier Rodríguez-Carrio; Călin D Popa; Michael T Nurmohamed; Gabriella Szűcs; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2021-04-08       Impact factor: 20.543

Review 7.  Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.

Authors:  Narendra N Khanna; Ankush D Jamthikar; Deep Gupta; Matteo Piga; Luca Saba; Carlo Carcassi; Argiris A Giannopoulos; Andrew Nicolaides; John R Laird; Harman S Suri; Sophie Mavrogeni; A D Protogerou; Petros Sfikakis; George D Kitas; Jasjit S Suri
Journal:  Curr Atheroscler Rep       Date:  2019-01-25       Impact factor: 5.113

Review 8.  Atherosclerotic vascular disease in the autoimmune rheumatologic woman.

Authors:  Reto Daniel Kurmann; Rekha Mankad
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

Review 9.  Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Authors:  Federico Carbone; Aldo Bonaventura; Luca Liberale; Sabrina Paolino; Francesco Torre; Franco Dallegri; Fabrizio Montecucco; Maurizio Cutolo
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

10.  Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.

Authors:  Gustavo Nogueira Schincariol Vicente; Ivânio Alves Pereira; Gláucio Ricardo Werner de Castro; Licia Maria Henrique da Mota; Ana Paula Carnieletto; Dhara Giovanna Santin de Souza; Fabiana Oenning da Gama; Ana Beatriz Vargas Santos; Cleandro Pires de Albuquerque; Manoel Barros Bértolo; Paulo Louzada Júnior; Rina Dalva Neubarth Giorgi; Sebastião Cezar Radominski; Maria Fernanda Brandão Resende Guimarães; Karina Rossi Bonfiglioli; Maria de Fátima Lobato da Cunha Sauma; Claiton Viegas Brenol; Geraldo da Rocha Castelar Pinheiro
Journal:  Adv Rheumatol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.